L87.0
Keratosis follicularis et parafollicularis in cutem penetrans
Clinical Classification Guidelines
Inclusion Terms
- Kyrle disease
- Hyperkeratosis follicularis penetrans
Medical Intelligence & Overview
Kyrle disease, also known as hyperkeratosis follicularis penetrans, is a rare skin condition characterized by the abnormal buildup of keratin, leading to the formation of keratotic lesions on the skin. It falls under the ICD-10 code L87.0 and is considered a type of perforating disorder where keratinous material penetrates deeper into the skin layers. This condition commonly affects middle-aged adults and can occur in various parts of the body, especially the limbs. Understanding Kyrle disease helps in recognizing its features and management options.
Causes & Symptoms
Clinical Causes: Unknown exact cause, but associated conditions such as diabetes mellitus and chronic kidney disease are common Genetic predisposition may play a role Chronic skin trauma or inflammation Altered keratinization process leading to abnormal keratin deposits Potential link to metabolic or endocrine disturbances
Key Symptoms: Multiple small, crater-like papules or keratotic plugs Lesions often have a central keratinous plug Culture of skin may show keratin debris underneath the skin surface Lesions commonly appear on the shins, thighs, arms, and trunk Itching or mild discomfort in affected areas Possible secondary skin infections due to scratching or open lesions
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a thorough skin examination, observing characteristic lesions. A skin biopsy may be performed to confirm the diagnosis by revealing keratin-filled invaginations penetrating the dermis. Differential diagnoses include other perforating dermatoses, such as perforating folliculitis or reactive perforating collagenosis. Laboratory tests may include blood work to identify associated systemic conditions like diabetes or kidney disease. Imaging is rarely necessary but can help assess underlying tissue involvement if larger lesions are present.
Treatment Protocols: Management of Kyrle disease focuses on controlling symptoms and addressing underlying conditions. Common approaches include: - **Topical therapies:** Use of keratolytic agents such as salicylic acid, urea, or tretinoin to soften and reduce hyperkeratosis. - **Systemic treatments:** In cases linked with systemic illnesses, controlling the primary condition may improve skin lesions. - **Phototherapy:** Certain light-based therapies might be beneficial for resistant cases. - **Preventive measures:** Regular moisturizing, avoiding skin trauma, and managing scratching can help reduce lesion formation. - **Monitoring:** Regular follow-up to monitor lesions and associated health issues. It is important to consult healthcare professionals for personalized treatment plans suitable for individual cases.
Clinical Advice & FAQs
Billing Guidance
Is L87.0 a billable ICD-10 code?
Yes, L87.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L87.0?
Clinical documentation must specify the nature of Keratosis follicularis et parafollicularis in cutem penetrans and any associated comorbidities for accurate reporting.
Cite this Clinical Reference